Cite
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
MLA
Gavriilaki, E.Dalampira, D.Theodorakakou, F.Liacos, C. I.Kanellias, N.Eleutherakis-Papaiakovou, E.Terpos, E.Gavriatopoulou, M.Verrou, E.Triantafyllou, T.Sevastoudi, A.Koravou, E. E.Touloumenidou, T.Varelas, C.Papalexandri, A.Sakellari, I.Dimopoulos, M. A.Kastritis, E.Katodritou, E. Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1478899701&authtype=sso&custid=ns315887.
APA
Gavriilaki, E. D. D. T. F. L. C.-I. K. N. E.-P. E. T. E. G. M. V. E. T. T. S. A. K. E.-E. T. T. V. C. P. A. S. I. D. M. A. K. E. K. E. (2022). Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.
Chicago
Gavriilaki, E. Dalampira, D. Theodorakakou, F. Liacos, C.-I. Kanellias, N. Eleutherakis-Papaiakovou, E. Terpos, E. Gavriatopoulou, M. Verrou, E. Triantafyllou, T. Sevastoudi, A. Koravou, E.-E. Touloumenidou, T. Varelas, C. Papalexandri, A. Sakellari, I. Dimopoulos, M.A. Kastritis, E. Katodritou, E. 2022. “Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1478899701&authtype=sso&custid=ns315887.